Literature DB >> 25785254

Accuracy of cardiogoniometry compared with electrocardiography in the diagnosis of coronary artery disease.

Behshid Ghadrdoost1, Majid Haghjoo2, Ata Firouzi3.   

Abstract

BACKGROUND: Cardiogoniometry (CGM) is a novel spatiotemporal electrocardiographic method utilizing computer-assisted three-dimensional data on cardiac potentials.
OBJECTIVES: This study compares the accuracy of CGM and electrocardiography (ECG) by detecting coronary artery disease (CAD) with reference to angiography as a well-known gold standard. PATIENTS AND METHODS: A total of 390 patients undergoing coronary angiography with CAD were enrolled. CGM was performed a few hours prior to coronary angiography. A standard 12-lead ECG was recorded after the CGM. The CGM and ECG results were recorded and analyzed by an independent investigator blinded to all patient data and the results of the coronary angiography.
RESULTS: The coronary angiography showed a normal coronary artery in 263 patients (67.4%). A median of CGM score was 1 (0-2), the minimum score was 0 and maximum score was 8. A total of 90 patients (31%) showed predefined ST-segment/T-wave changes in the resting 12-lead ECG. CGM yielded a sensitivity of 84% and specificity of 81% and the ECG yielded a sensitivity of 29% and specificity of 67% when compared with the coronary angiography.
CONCLUSIONS: CGM is a non-invasive technique recently developed for quantitative three-dimensional vectorial analysis of myocardial activity and detection of ischemia and infarction. This technique is clearly more sensitive and more specific than a standard resting 12-lead ECG.

Entities:  

Keywords:  Coronary Angiography; Electrocardiography; Vectorcardiography

Year:  2015        PMID: 25785254      PMCID: PMC4347729          DOI: 10.5812/cardiovascmed.25547

Source DB:  PubMed          Journal:  Res Cardiovasc Med        ISSN: 2251-9572


1. Background

The resting 12-lead electrocardiogram (ECG) is an established diagnostic test in evaluating patients with CAD. However, as a diagnostic tool, the procedure is limited by low sensitivity, particularly in stable and/or asymptomatic patients (1). Furthermore, automated interpretation of the ECG is not always reliable (2) and the diagnostic yield depends highly on the ECG expertise of the reader (3). Therefore, the exercise ECG has been established as the standard method in a primary setting for detection of CAD in patients with suspected stable angina pectoris or without symptoms. However, exercise ECGs are often not meaningful due to limited stress capacity of the patient or are even contraindicated (4). CGM is a novel electrodiagnostic method that analyzes three-dimensional information on cardiac potentials (5, 6). Additionally, CGM provides quantitative computer analysis of this three-dimensional information. The rating does not require a qualitative evaluation by an expert. CGM showed a prospective diagnostic sensitivity of 64–79%, and a specificity of 82% in detecting CAD (6, 7).

2. Objectives

We therefore sought to investigate the accuracy of CGM compared with ECG to detect patients with CAD before coronary angiography as a gold standard method.

3. Patients and Methods

3.1. Patients

A total of 400 patients with suspected CAD, candidates for first elective coronary angiography, were enrolled. The study protocol was approved by our local Ethics Committee. Patients who had atrial fibrillation, frequent premature beats, left bundle branch block, severe valvular disease, and history of previous cardiac surgery were excluded. CGM was obtained a few hours prior to coronary angiography. Written informed consent was obtained from all patients before study. A cardiologist who performed the coronary angiography was blinded to the results of the ECG and CGM. All ECGs were analyzed by one independent investigator blinded to all patient data. All CGMs were obtained by nurses who were blinded to the results of the ECG and angiography.

3.2. Cardiogoniometry Protocol

During CGM recording, patients laid in a supine position and after a normal expiration, held their breath for 12–15 seconds during measurement. The CGMs were recorded by an independent investigator blinded to all patient data, including the results of the angiography. A standard 12-lead ECG was recorded after the CGM. The principles of the CGM have been published in detail elsewhere (6-8). Briefly, four electrodes were placed perpendicular at four points on the patients thorax: point 1, at point V4 of Wilson, in the 5th intercostal space on mid clavicular line; point 2, at a point opposite to electrode 1 on back (at point V8 of Wilson); point 3 located perpendicularly above electrode 1 at 0.7 times the distance between point 1 and 2; and point 4 placed to the right of point 3 at the same distance between points 1 and 3 horizontally. The leads are defined as below: 4-2: D (dorsal), 4-1: A (anterior), 2-1: I (inferior), 4-3: Ho (horizontal), and 3-1: Ve (vertical) (Figure 1) (http://www.enverdis.com/cardiogoniometry/). Points 4-2-1 defined the oblique sagittal plane OSP and points 4-3-1 defined the frontal plane. The third plane was orthogonal to the two other planes and contained point 3 and it was the sagittal plane perpendicular to the OSP. Projection X was oriented in an antero-dorsal direction and crossed the OSP and the sagittal plane perpendicularly. Projection Y was oriented in a baso-apical direction and lays in the OSP (4-2-1) and the frontal plane (4-3-1). Projection Z was oriented in the superior-inferior direction relative to the OSP and laid in the frontal plane (4-3-1) and the sagittal plane perpendicular to the OSP. The direction of X-, Y-, and Z-axis and the magnitude of potential for reach point determined T time. (Figure 2) (http://www.enverdis.com/cardiogoniometry/). These vectors can be represented as a loop (Figure 3) (http://www.enverdis.com/cardiogoniometry/).
Figure 1.

Configuration and Data Registration by Leads A, D, and Ve

Figure 2.

Determination of a Loop Point at Time t Form the X, Y, and Z Channels

Figure 3.

Representation of Loop Generation on the Time Curve and Determination of the Maximum Vectors

CGM software in addition to showing three-dimensional loops also displays the maximum range of the reference vectors. The parameters obtained from CGM can be divided into the following main classes as follows: angles, amplitudes, shapes, and eccentricities describing the P-, R-, and T-loops, potential distributions of the P-, R-, and ST/T-loops in octants, and velocities (absolute and ratios) of the P-, R-, and T-loops. In a normal situation, the maximum vectors of R and T (depolarization and repolarization) are located directly to each other and within the standard fields (Figure 4) but in pathologic situation the maximum vectors of R and T are distinctly running in different directions, the T maximum vectors are scattered. Thus, indicating ischemia, the R maximum vectors are clearly located outside of standard field and are strongly scattered (Figure 5).
Figure 4.

Healthy Potential Propagation

Figure 5.

Pathologic Potential Propagation

3.3. Twelve-Lead Electrocardiography

The resting 12-lead ECG was recorded prior to coronary angiography. All ECGs were analyzed by one independent investigator blinded to all patient data. ECGs with persistent or transient horizontal or down-sloping ST depression ≥ 0.05 mV in two contiguous leads and/or T inversion ≥ 0.1 mV in two contiguous leads with prominent R wave were regarded as indicative of myocardial ischemia. Therefore, all registered positive; with all other patients registered as negative (9, 10). Statistical analysis: Statistical analyses were performed with SPSS (ver 15; SPSS Inc. Chicago, Illinois). Data were expressed as mean values ± standard deviation for interval and count (%) for categorical variables. The McNemar test was performed to compare sensitivities, specificities, and the diagnostic accuracy of CGM and ECG. P values < 0.05 were considered significant.

4. Results

4.1. Demographic and Clinical Findings

A total of 400 patients were enrolled in this study. Ten patients who had atrial fibrillation, left bundle branch block, and severe valvular disease were excluded. A total of 390 patients (316 men, mean age: 54 ± 11 years) who were candidates for coronary angiography were included and patients suspected of having CAD and present with new onset chest pain, elevated cardiovascular risk, abnormal echocardiogram, positive stress ECG test, and/or myocardial perfusion scintigraphies (11, 12). All patients were in sinus rhythm at the time of the study and 90 patients (31%) showed predefined ST-segment/T-wave changes in resting 12-lead ECGs. Coronary angiography showed normal coronary artery in 263 patients (67.4%), one-vessel disease in 65 patients (16.7%), two-vessel disease in 39 patients (10%), and three-vessel disease in 23 patients (5.9%). Clinically significant CAD has been defined as one or more lesions with > 70% stenosis or diameter narrowing (> 50% for left main CAD). Minimal coronary disease is defined at that time as maximal stenosis < 50% (13).

4.2. Cardiogoniometry

Main diagnoses were normal CGM in 235 patients (60%) and abnormal CGM in 155 patients (40%). Median of CGM score was 1 (0–2), the minimum score was 0 and maximum score was 8. CGM yielded a sensitivity of 84 (95% CI: 75.32% to 88.99%), a specificity of 81% (95% CI: 76.54% to 86.23%), a positive predictive value (PPV) of 69% (95% CI: 61.12% to 76.20%), and a negative predictive value (NPV) of 89% (95% CI: 87.16% to 94.72%) (Table 1).
Table 1.

Diagnostic Yield of Cardiogoniometry Compared With Gold Standard of Coronary Angiography

VariablesCardiogoniometry [a]95%CI
Sensitivity 84 [b]75.32-88.99 [b]
Specificity 81 [b]76.54-86.23 [b]
Positive predictive value 69 [b]61.12-76.20 [b]
Negative predictive value 89 [b]87.16-94.72 [b]
Positive likelihood ratio 4.623.54-6.03
Negative likelihood ratio 0.190.13-0.29

a P value < 0.001.

b Data are presented as %.

The standard resting 12-lead ECG yielded a sensitivity of 29% (95% CI: 22.12% to 38.68%), a specificity of 67% (95% CI: 60.12% to 75.01%), a NPV of 55% (95% CI: 48.08% to 62.31%), and a PPV of 42% (95% CI: 31.88% to 53.09%) (Table 2).
Table 2.

Diagnostic Yield of 12-Lead Electrocardiography Compared With Gold Standard of Coronary Angiography [a]

VariablesResting 12-Lead ECG [b]95%CI
Sensitivity 29 [c]22.12-38.68 [c]
Specificity 67 [c]60.12-75.01 [c]
Positive predictive value 42 [c]31.88-53.09 [c]
Negative predictive value 55 [c]48.08-62.31 [c]
Positive likelihood ratio 0.930.66 to 1.32
Negative likelihood ratio 1.030.88 to 1.21

a Abbreviation: ECG, electrocardiography.

b P value < 0.001.

c Data are presented as %.

The CGM score was also significantly associated with the number of abnormal coronary arteries (P value > 0.001) and the score was significantly higher in two- and three-vessel-disease patients. CGM yielded a sensitivity of 84% and specificity of 81% and ECG yielded a sensitivity of 29% and specificity of 67% compared with coronary angiography. a P value < 0.001. b Data are presented as %. a Abbreviation: ECG, electrocardiography. b P value < 0.001. c Data are presented as %.

5. Discussion

Non-invasive detection of myocardial ischemia has been done by using ECG, echocardiography, and myocardial perfusion imaging for a long time. Although the ECG has become indispensable in cardiology and is available in every hospital, there are limitations that make ECG unsuitable for detecting CAD: ECG is neither sensitive nor specific with respect to ST-segment depressions and inverted T waves and pathological Q-waves not frequently found in all patients with previous myocardial infarction (1). Recently, CGM as a novel method has been developed with the addition of a third dimension in the analysis of the hearts electrical potential. This method is simpler than ECG (4-lead instead of 12-lead) and provides exact cardiac three-dimensional electrophysiological data (13). The current study was performed at a referral center of cardiology on 400 patients with suspected CAD who were candidates for coronary angiography. The CGM score correlated significantly with the number of affected coronary arteries. The score was significantly higher in two-vessel and three-vessel-disease patients. CGM yielded a sensitivity of 83%, a specificity of 88%, a PPV of 69%, and a NPV of 84.3%. The accuracy of CGM with reference to coronary angiography as a gold standard was 0.53. The defined ECG criteria for detection of coronary artery ischemia yielded a sensitivity of 26%, a specificity of 67%, a PPV of 39.4%, and a NPV of 65%. The accuracy of ECG with reference to coronary angiography was 0.11. Schupbach et al. (14) studied 793 patients with CAD and reported a sensitivity of 64% and specificity of 84% for CGM and a sensitivity of 53% and a specificity of 75% for ECG, which is similar to the findings of the current study. Saner et al. have reported a sensitivity of 79% and a specificity of 82% for CGM in the detection of ischemic heart disease (15). The results of the present study should be interpreted in the light of certain limitations. There may be a referral bias as all patients were sent to a tertiary medical center for invasive cardiac assessment due to suspected myocardial ischemia. Therefore, our results may not be generalized to other populations. The results of this present study show that CGM is a useful method to diagnose CAD with better diagnostic accuracy than 12-lead ECGs does. CGMs can replace resting 12-lead ECGs in screening patients for myocardial ischemia because they are easier to use and do not need for an expert reader.
  13 in total

1.  Cardiogoniometric parameters for detection of coronary artery disease at rest as a function of stenosis localization and distribution.

Authors:  Thomas Huebner; W M Michael Schuepbach; Andrea Seeck; Ernst Sanz; Bernhard Meier; Andreas Voss; Roland Pilgram
Journal:  Med Biol Eng Comput       Date:  2010-03-19       Impact factor: 2.602

2.  Common errors in computer electrocardiogram interpretation.

Authors:  Maya E Guglin; Deepak Thatai
Journal:  Int J Cardiol       Date:  2006-01-13       Impact factor: 4.164

3.  Differences between local investigator and core laboratory interpretation of the admission electrocardiogram in patients with unstable angina pectoris or non-Q-wave myocardial infarction (a Thrombin Inhibition in Myocardial Ischemia [TRIM] substudy).

Authors:  L Holmvang; P Hasbak; P Clemmensen; G Wagner; P Grande
Journal:  Am J Cardiol       Date:  1998-07-01       Impact factor: 2.778

Review 4.  Pathophysiology and clinical implications of cardiac memory.

Authors:  Darwin Jeyaraj; Mahi Ashwath; David S Rosenbaum
Journal:  Pacing Clin Electrophysiol       Date:  2009-12-16       Impact factor: 1.976

5.  Cardiogoniometry.

Authors:  E Sanz; J P Steger; W Thie
Journal:  Clin Cardiol       Date:  1983-05       Impact factor: 2.882

Review 6.  Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning.

Authors:  Alejandro N Mazzadi; Xavier André-Fouët; Nicolas Costes; Pierre Croisille; Didier Revel; Marc F Janier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-07-21       Impact factor: 4.733

Review 7.  Electrocardiologic and related methods of non-invasive detection and risk stratification in myocardial ischemia: state of the art and perspectives.

Authors:  Thomas Huebner; Matthias Goernig; Michael Schuepbach; Ernst Sanz; Roland Pilgram; Andrea Seeck; Andreas Voss
Journal:  Ger Med Sci       Date:  2010-10-11

8.  Cardiogoniometry: a new noninvasive method for detection of ischemic heart disease.

Authors:  H Saner; H R Baur; E Sanz; H P Gurtner
Journal:  Clin Cardiol       Date:  1983-05       Impact factor: 2.882

9.  Current international guidelines for the investigation of patients with suspected coronary artery disease.

Authors:  Ozan Mehmet Demir; Khaled Alfakih; Sven Plein
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-09-03       Impact factor: 6.875

10.  Cardiogoniometry as a diagnostic tool in patients with acute coronary syndromes: results of the CGM@ACS trial.

Authors:  Ralph Tölg; Uwe Zeymer; Ralf Birkemeyer; Rainer Wessely; Holger Eggebrecht; Wolfgang Bocksch; Steffen Schneider; Gert Richardt; Christian Hamm
Journal:  Clin Res Cardiol       Date:  2012-04-07       Impact factor: 5.460

View more
  5 in total

1.  Peripheral blood circular RNA hsa_circ_0124644 can be used as a diagnostic biomarker of coronary artery disease.

Authors:  Zhenzhou Zhao; Xuejie Li; Chuanyu Gao; Dongdong Jian; Peiyuan Hao; Lixin Rao; Muwei Li
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

2.  Cardiogoniometry Compared to Fractional Flow Reserve at Identifying Physiologically Significant Coronary Stenosis: The CARDIOFLOW Study.

Authors:  Oliver I Brown; Andrew L Clark; Raj Chelliah; Benjamin J Davison; Adam N Mather; Michael S Cunnington; Joseph John; Albert Alahmar; Richard Oliver; Konstantinos Aznaouridis; Angela Hoye
Journal:  Cardiovasc Eng Technol       Date:  2018-04-12       Impact factor: 2.495

3.  CircRNA ZNF609 in peripheral blood leukocytes acts as a protective factor and a potential biomarker for coronary artery disease.

Authors:  Bin Liang; Menglan Li; Qianyun Deng; Chen Wang; Jialing Rong; Siying He; Yang Xiang; Fang Zheng
Journal:  Ann Transl Med       Date:  2020-06

4.  Plasma Exosomal S1PR5 and CARNS1 as Potential Non-invasive Screening Biomarkers of Coronary Heart Disease.

Authors:  Feng Xiong; Rui Mao; Ruohan Zhao; Lijuan Zhang; Kunyue Tan; Chunxia Liu; Shuzhen Wang; Min Xu; Yi Li; Tongtong Zhang
Journal:  Front Cardiovasc Med       Date:  2022-06-28

5.  Plasma-Derived Exosomal Circular RNA hsa_circ_0005540 as a Novel Diagnostic Biomarker for Coronary Artery Disease.

Authors:  Wei-Peng Wu; Yan-Hong Pan; Meng-Yun Cai; Jin-Ming Cen; Can Chen; Lei Zheng; Xinguang Liu; Xing-Dong Xiong
Journal:  Dis Markers       Date:  2020-06-30       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.